Computational study of the effects of protein tyrosine nitrations on the catalytic activity of human thymidylate

Adam Jarmuła1, Wojciech Rode

  • 1Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur St., 02-093 Warszawa, Poland. a.jarmula@nencki.gov.pl

Insights

Tyrosine nitration, a modification of proteins like thymidylate synthase (TS), can reduce its anticancer drug target activity. Computational studies reveal specific tyrosine sites on human TS (hTS) are more sensitive to nitration, impacting enzyme function.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Tyrosine nitration is a post-translational modification affecting protein function and structure.
  • Thymidylate synthase (TS) is a key anticancer therapeutic target, and its nitrated forms have been observed in tissues.
  • Previous in vitro studies showed human TS (hTS) nitration reduces catalytic activity.

Purpose of the Study:

  • To computationally predict the impact of nitration at seven identified tyrosine residues on hTS activity.
  • To understand the structure-activity relationship of tyrosine nitration in hTS.

Main Methods:

  • Utilized a combined computational approach: molecular dynamics, essential dynamics, and free energy computations.
  • Simulations were based on the crystal structure of hTS in a ternary complex with dUMP and a tetrahydrofolate analogue.

Main Results:

  • Nitration of five specific tyrosine residues (Y33, Y135, Y230, Y258, Y301) significantly reduced hTS activity.
  • Nitration of tyrosine residues Y65 and Y213 showed minimal or no impact on enzyme activity.
  • The influence of nitration on hTS activity was found to be distance-dependent.

Conclusions:

  • Tyrosine nitration significantly impacts hTS structure, dynamics, and catalytic properties.
  • Specific tyrosine residues are critical for maintaining hTS activity when subjected to nitration.
  • These findings provide insights into the role of post-translational modifications in enzyme regulation and drug targeting.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...